| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |